Interference with electrophoretic and immunofixation techniques: case report
This is a preview of subscription content, log in to check access.
De Santis E, et al. Interference by biological anti-cancer drugs: The case of Bevacizumab. Biochimica Clinica 42: e5-e7, No. 1, Jan 2018. Available from: URL: http://doi.org/10.19186/BC_2018.011 [Italian; summarised from a translation] - ItalyGoogle Scholar